Description
Tridek-One is a private biotechnology company formed out of INSERM (Paris, France), developing first-in-class immune checkpoint agonists to restore the immune balance in patients living with auto-immune diseases.
See the website
Case studies
Tridek-One SAS is a leading biotech start-up specialized in the research and development of CD31 agonists to restore the immune balance
Read more